SPDR S&P Biotech ETF $XBI Shares Sold by Employees Retirement System of Texas

Employees Retirement System of Texas reduced its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 725,272 shares of the exchange traded fund’s stock after selling 13,000 shares during the period. Employees Retirement System of Texas owned 1.09% of SPDR S&P Biotech ETF worth $88,432,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of XBI. JPMorgan Chase & Co. grew its holdings in shares of SPDR S&P Biotech ETF by 27.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock worth $1,356,582,000 after purchasing an additional 2,900,633 shares during the period. Assetmark Inc. boosted its holdings in SPDR S&P Biotech ETF by 1,042,265.6% during the 4th quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock valued at $77,528,000 after acquiring an additional 635,782 shares during the period. Greenwoods Asset Management Hong Kong Ltd. purchased a new stake in SPDR S&P Biotech ETF during the 3rd quarter worth approximately $55,613,000. Ameriprise Financial Inc. lifted its holdings in SPDR S&P Biotech ETF by 123.0% during the 2nd quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after buying an additional 481,408 shares in the last quarter. Finally, Main Street Research LLC purchased a new position in SPDR S&P Biotech ETF in the fourth quarter valued at $43,959,000.

SPDR S&P Biotech ETF Stock Up 1.3%

Shares of SPDR S&P Biotech ETF stock opened at $133.35 on Wednesday. SPDR S&P Biotech ETF has a 52-week low of $78.06 and a 52-week high of $139.19. The company has a market capitalization of $8.51 billion, a P/E ratio of 11.47 and a beta of 0.85. The company has a 50 day moving average of $130.23 and a 200 day moving average of $125.49.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.